Our client aimed to unify R&D, patient registry, and commercial data—previously held in silos—to gain integrated insights into Diabetes and Obesity. They wanted to connect clinical trial outcomes with real-world evidence (RWE) data and enhance their ability to generate actionable insights across teams.

We developed a cloud-native enterprise data platform that integrated R&D, RWE, and market data into a single, secure, and scalable environment. The solution automated data ingestion from multiple sources, streamlined analytics, and provided intuitive visualization tools for faster, evidence-based insights.​Robust governance and role-based access controls ensured compliance and data integrity, while cross-functional collaboration was strengthened through a unified and trusted data ecosystem.​This platform enabled faster decision-making, improved data sharing, and created a solid foundation for ongoing research and innovation.

We helped our client:​

• achieve end-to-end visibility from lab research to patient outcomes. This improved therapy prioritization, supported more informed pipeline decisions, and strengthened launches and commercial strategies in core markets.